ACUTE MYELOID LEUKEMIAS
Clinical trials for ACUTE MYELOID LEUKEMIAS explained in plain language.
Never miss a new study
Get alerted when new ACUTE MYELOID LEUKEMIAS trials appear
Sign up with your email to follow new studies for ACUTE MYELOID LEUKEMIAS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
First human trial launches for experimental blood cancer drug
Disease control Recruiting nowThis is a first-in-human study testing a new drug called STX-0712 for patients with advanced forms of blood cancers (CMML and AML) who have run out of standard treatment options. The main goal is to find a safe dose and see how the body handles the drug, while also checking for e…
Matched conditions: ACUTE MYELOID LEUKEMIAS
Phase: PHASE1 • Sponsor: Solu Therapeutics, Inc • Aim: Disease control
Last updated Apr 04, 2026 05:07 UTC
-
Major trial aims to boost chemo power against aggressive leukemia
Disease control Recruiting nowThis large, late-stage study is testing whether adding an experimental drug called revumenib to standard chemotherapy works better than chemotherapy alone for adults newly diagnosed with a specific genetic type of acute myeloid leukemia (AML). The goal is to see if the combinatio…
Matched conditions: ACUTE MYELOID LEUKEMIAS
Phase: PHASE3 • Sponsor: Syndax Pharmaceuticals • Aim: Disease control
Last updated Mar 27, 2026 12:41 UTC
-
New hope for Tough-to-Treat leukemia: First-in-Human trial tests novel drug combo
Disease control Recruiting nowThis study is testing the safety and early effectiveness of a new oral drug, SNDX-5613, when given alongside standard intensive chemotherapy to adults newly diagnosed with a fast-growing blood cancer called acute myeloid leukemia (AML). The trial is specifically for people whose …
Matched conditions: ACUTE MYELOID LEUKEMIAS
Phase: PHASE1 • Sponsor: Syndax Pharmaceuticals • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC